RT Journal
A1 Frampton AE, Pai M, Krell J, Vlavianos P, Jiao LR, Spalding DC
T1 THe “malignant truth” about the recurrence of pancreatic intraductal papillary mucinous neoplasms
JF Archives of Surgery
JO Archives of Surgery
YR 2012
FD October 1
VO 147
IS 10
SP 977
OP 980
DO 10.1001/archsurg.2012.2287
UL http://dx.doi.org/10.1001/archsurg.2012.2287
AB 
We thank Moriya and Traverso1 for their recent report presenting data from their longitudinal cohort study describing the recurrence of intraductal papillary mucinous neoplastic (IPMN) lesions in the pancreatic remnant after previous partial resection. Some of these data were also discussed in a recent review article.2 The study by Moriya and Traverso1 further reinforces the difficulties that we face when treating IPMN disease and presents some interesting findings, some of which have already been described by others. In our opinion, this cohort study1 has added to our understanding of IPMN recurrence, and we are therefore grateful to Moriya and Traverso1 for their efforts. A few points, however, deserve mention.